Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA.
Chest. 2010 Sep;138(3):559-67. doi: 10.1378/chest.09-2933. Epub 2010 May 27.
ARDS may occur after either septic or nonseptic injuries. Sepsis is the major cause of ARDS, but little is known about the differences between sepsis-related and non-sepsis-related ARDS.
A total of 2,786 patients with ARDS-predisposing conditions were enrolled consecutively into a prospective cohort, of which 736 patients developed ARDS. We defined sepsis-related ARDS as ARDS developing in patients with sepsis and non-sepsis-related ARDS as ARDS developing after nonseptic injuries, such as trauma, aspiration, and multiple transfusions. Patients with both septic and nonseptic risks were excluded from analysis.
Compared with patients with non-sepsis-related ARDS (n = 62), patients with sepsis-related ARDS (n = 524) were more likely to be women and to have diabetes, less likely to have preceding surgery, and had longer pre-ICU hospital stays and higher APACHE III (Acute Physiology and Chronic Health Evaluation III) scores (median, 78 vs 65, P < .0001). There were no differences in lung injury score, blood pH, Pao(2)/Fio(2) ratio, and Paco(2) on ARDS diagnosis. However, patients with sepsis-related ARDS had significantly lower Pao(2)/Fio(2) ratios than patients with non-sepsis-related ARDS patients on ARDS day 3 (P = .018), day 7 (P = .004), and day 14 (P = .004) (repeated-measures analysis, P = .011). Compared with patients with non-sepsis-related ARDS, those with sepsis-related had a higher 60-day mortality (38.2% vs 22.6%; P = .016), a lower successful extubation rate (53.6% vs 72.6%; P = .005), and fewer ICU-free days (P = .0001) and ventilator-free days (P = .003). In multivariate analysis, age, APACHE III score, liver cirrhosis, metastatic cancer, admission serum bilirubin and glucose levels, and treatment with activated protein C were independently associated with 60-day ARDS mortality. After adjustment, sepsis-related ARDS was no longer associated with higher 60-day mortality (hazard ratio, 1.26; 95% CI, 0.71-2.22).
Sepsis-related ARDS has a higher overall disease severity, poorer recovery from lung injury, lower successful extubation rate, and higher mortality than non-sepsis-related ARDS. Worse clinical outcomes in sepsis-related ARDS appear to be driven by disease severity and comorbidities.
ARDS 可能继发于感染性或非感染性损伤。感染是 ARDS 的主要病因,但关于感染相关性 ARDS 和非感染相关性 ARDS 之间的差异知之甚少。
连续纳入了 2786 例存在 ARDS 诱发因素的患者进入前瞻性队列,其中 736 例发生了 ARDS。我们将感染相关性 ARDS 定义为发生于脓毒症患者的 ARDS,而非感染相关性 ARDS 定义为继发于非感染性损伤(如创伤、误吸和多次输血)的 ARDS。有脓毒症和非脓毒症风险的患者被排除在分析之外。
与非感染相关性 ARDS 患者(n=62)相比,感染相关性 ARDS 患者(n=524)更可能为女性且患有糖尿病,更不可能有术前手术史,入住 ICU 前的住院时间更长,急性生理学和慢性健康评估 III 评分(APACHE III)更高(中位数,78 比 65,P<0.0001)。ARDS 诊断时两组间肺损伤评分、血 pH 值、动脉血氧分压/吸入氧分数(Pao2/Fio2)比值和动脉血二氧化碳分压(Paco2)均无差异。然而,感染相关性 ARDS 患者在 ARDS 第 3、7 和 14 天(重复测量分析,P=0.011)的 Pao2/Fio2 比值显著低于非感染相关性 ARDS 患者(P=0.018、P=0.004 和 P=0.004)。与非感染相关性 ARDS 患者相比,感染相关性 ARDS 患者 60 天死亡率更高(38.2%比 22.6%;P=0.016)、成功撤机率更低(53.6%比 72.6%;P=0.005)、无 ICU 天数更少(P=0.0001)和无机械通气天数更少(P=0.003)。多变量分析显示,年龄、APACHE III 评分、肝硬化、转移性肿瘤、入院时血清胆红素和葡萄糖水平以及活化蛋白 C 治疗与 60 天 ARDS 死亡率相关。调整后,感染相关性 ARDS 与 60 天死亡率增加无关(危险比,1.26;95%CI,0.71-2.22)。
与非感染相关性 ARDS 相比,感染相关性 ARDS 的整体疾病严重程度更高,肺损伤恢复更差,成功撤机率更低,死亡率更高。感染相关性 ARDS 患者临床结局更差可能是由疾病严重程度和合并症导致的。